Trulieve Cannabis Corp. (OTCMKTS:TCNNF) Sees Large Decline in Short Interest

Trulieve Cannabis Corp. (OTCMKTS:TCNNFGet Rating) saw a significant decline in short interest in the month of July. As of July 15th, there was short interest totalling 281,000 shares, a decline of 19.2% from the June 30th total of 347,600 shares. Based on an average trading volume of 497,800 shares, the short-interest ratio is presently 0.6 days.

Trulieve Cannabis Stock Down 1.1 %

OTCMKTS TCNNF opened at $13.30 on Thursday. The business has a 50-day moving average price of $13.13 and a 200-day moving average price of $17.14. Trulieve Cannabis has a twelve month low of $10.95 and a twelve month high of $34.75.

Wall Street Analysts Forecast Growth

Separately, Alliance Global Partners cut their price target on Trulieve Cannabis from C$60.00 to C$50.00 in a report on Thursday, May 12th. Nine investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $69.63.

About Trulieve Cannabis

(Get Rating)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. It cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. The company produces flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with's FREE daily email newsletter.